Entera Bio Ltd - Warrants (02/07/2023) Long Term Debt

As of the most recent data (June 2026), ENTXW shows a long-term debt of $230K. That compares with $9K in the prior-year period — up 2411.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENTXW's long-term debt is now $230K (was $9K) — a 2411.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Entera Bio Ltd - Warrants (02/07/2023) is outperforming or lagging.

Tracking ENTXW's long-term debt over time shows whether Entera Bio Ltd - Warrants (02/07/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $230K That compares with $9K in the prior-year period — up 2411.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Entera Bio Ltd - Warrants (02/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $230K) with ownership activity and broader fundamentals.

Entera Bio Ltd - Warrants (02/07/2023)'s long-term debt is $230K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.